Search
OptimizeRx Corp
OPRXAdd to Watchlist
4.980USD
-0.100-1.97%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
93.45MMarket Cap
13.49P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of OptimizeRx Corp is 8.29, ranking 70 out of 489 in the Software & IT Services industry. The average price target is 24.00, with a high of 32.00 and a low of 17.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
12.400
Target Price
+144.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
114
Total
7
Median
13
Average
Company name
Ratings
Analysts
OptimizeRx Corp
OPRX
6
Meta Platforms Inc
META
66
Alphabet Inc Class A
GOOGL
62
Uber Technologies Inc
UBER
55
Netflix Inc
NFLX
52
Lyft Inc
LYFT
49
1
2
3
...
23
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is OptimizeRx Corp's expected revenue for the next quarter?
OptimizeRx Corp's expected revenue is 20.20M.
What is OptimizeRx Corp's price target?
Analysts forecast that OptimizeRx Corp's price target is USD 24.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 17.00.
How have OptimizeRx CorpOPRX's recent earnings per share performed?
The market expectation was USD -0.03, while OptimizeRx CorpOPRX's earnings per share (EPS) for the previous quarter was USD 0.27. EPS for the next quarter is expected at USD 0.13.
What is the analyst rating for OptimizeRx Corp?
Based on the ratings of OptimizeRx Corp's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
